*This position requires working onsite 3 days per week at our U.S. headquarters in Lake Zurich, IL.
*This position does not offer visa sponsorship either now or in the future.
• Salary Range: $170,000-200,000.
• Position is eligible to participate in an annual bonus plan with a target of 16% of the base salary.
• Position is eligible to participate in our medium-term incentive plan.
• Final pay determinations will depend on various factors, including, but not limited to experience level, education, knowledge, skills, and abilities.
• Our benefits and programs are comprehensive and thoughtfully crafted to ensure our colleagues live healthy lives and have support when it matters most. Benefits offered include a 401(k) plan with company contributions, paid vacation, holiday and personal days, employee assistance program, and health benefits to include medical, prescription drug, dental and vision coverage.Responsibilities
- Define and execute the strategic vision for chargeback operations, aligning with financial, commercial strategies, and compliance objectives.
- Act as a strategic advisor to executive leadership, providing insights into industry trends, regulatory changes, and market dynamics impacting CFS.
- Establish, monitor, and report on KPIs to measure financial impact, operational efficiency, and compliance performance.
- Serve as the enterprise expert on Gross-to-Net, delivering insights and strategies that protect revenue and optimize profitability across all channels.
- Provide overall oversight of the chargeback lifecycle, setting governance standards, policies, and controls that ensure accuracy, timeliness, and audit readiness across high-volume transactions.
- Design and implement wholesaler monitoring processes in partnership with Treasury, CFS, and Commercial teams to ensure contract adherence and financial accuracy.
- Establish and oversee governance, controls, and systems to ensure accuracy and audit readiness of chargeback processing. Set escalation protocols and governance frameworks for exception management and dispute resolution, ensuring financial exposure is minimized and external partnerships are strategically managed.
- Partner with IT and systems teams to design and implement automation tools, reporting dashboards, and real-time decision-support capabilities.
- Collaborate with Treasury to align chargeback cash flow forecasting with broader financial planning and liquidity strategies.
- Provide guidance and support for the implementation of new business initiatives impacting chargebacks, credit & collections, and treasury processes.
- Build, lead, and mentor a high-performing team of chargeback analysts, fostering a culture of accountability, innovation, and operational excellence.
- Provide coaching, performance management, and career development opportunities to strengthen team capabilities and retention.
- Develop, refine, and present regular reporting on chargeback trends, KPIs, and root cause analyses.
Job Requirements:
- Bachelor’s degree in finance, accounting, or related field.
- 10+ years’ related experience (Chargebacks, Rebates, Finance Operations)
- 5+ years of management experience
- Experience in pharmaceutical, medical device or related healthcare industry experience required.
- Proficiency in ERP systems and chargeback platforms (e.g., SAP, Model N, Revitas).
We offer an excellent salary and benefits package including medical, dental and vision coverage, as well as life insurance, disability, 401K with company contribution, and wellness program.
Fresenius Kabi is an Equal Opportunity/Affirmative Action employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, citizenship, immigration status, disabilities, or protected veteran status.
Top Skills
What We Do
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The company’s products and services are used for the therapy and care of critically and chronically ill patients.
Its product portfolio comprises a range of highly complex biopharmaceuticals, clinical nutrition, medical technologies, and I.V. generic drugs. Within biopharmaceuticals, Fresenius Kabi offers, among others, biosimilar drugs with a focus on autoimmune diseases and oncology. The company’s clinical nutrition offering includes a wide selection of enteral and parenteral nutrition products. In the segment of medical technologies, its offering includes vital disposables, infusions pumps, apheresis machines, cell therapy devices, and more. Fresenius Kabi puts essential medicines and technologies in the hands of people who help patients and finds the best answers to the challenges they face.
Following its strategy “Vision 2026”, which is a key part of the #FutureFresenius program of the Fresenius healthcare group, the company is furthermore committed to increase efficiencies in the therapy and care of patients and improve access to high-quality healthcare around the globe. Fresenius Kabi aspires to be leading globally in its product segments – all for the benefit of patients, its customers, and its stakeholders.
Fresenius Kabi Community Guidelines and User Information:
https://www.fresenius-kabi.com/social-media-terms-conditions
Imprint: https://www.fresenius-kabi.com/imprint

.png)






